Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 7, 2016
Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4'-OH-bupropion in vitroJennifer E Sager, Lauren S L Price, Nina Isoherranen
Biopharmaceutics & Drug Disposition|December 30, 2014
Dealing with the complex drug-drug interactions: towards mechanistic modelsManthena V Varma, K Sandy Pang, Nina Isoherranen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 28, 2017
Inhibition of the all-trans Retinoic Acid (atRA) Hydroxylases CYP26A1 and CYP26B1 Results in Dynamic, Tissue-Specific Changes in Endogenous atRA SignalingFaith Stevison, Cathryn Hogarth, Sasmita Tripathy, et al.
Molecular Pharmacology|February 25, 2018
CYP26C1 Is a Hydroxylase of Multiple Active Retinoids and Interacts with Cellular Retinoic Acid Binding ProteinsGuo Zhong, David Ortiz, Alex Zelter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 23, 2015
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model VerificationJennifer E Sager, Jingjing Yu, Isabelle Ragueneau-Majlessi, et al.
Methods in Enzymology|May 4, 2020
Analysis of vitamin A and retinoids in biological matricesLindsay C Czuba, Guo Zhong, King C Yabut, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 2, 2017
Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug InteractionsWeize Huang, Mariko Nakano, Jennifer Sager, et al.
ACS Medicinal Chemistry Letters|May 17, 2023
Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinolJessica L Beers, Aurora K Authement, Nina Isoherranen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2013
Inhibition of CYP2C19 and CYP3A4 by omeprazole metabolites and their contribution to drug-drug interactionsYoshiyuki Shirasaka, Jennifer E Sager, Justin D Lutz, et al.
Pageof 18